Faro, which develops data models and AI tools to speed up clinical trials, raised a $37.3M Series B co-led by Merck Global Health Innovation Fund and S32 (Dealroom.co)

Faro, a company focused on developing data models and AI tools to accelerate clinical trials, successfully raised a $37.3M Series B funding round. This investment was co-led by the Merck Global Health Innovation Fund and S32, as reported by Dealroom.co. The capital will be utilized to further develop their AI tools, which are designed to enhance the efficiency and speed of clinical trials.